Zydus gets USFDA approval for Indomethacin suppository with CGT designation EP News Bureau Aug 3, 2023 The company has been granted 180-day CGT exclusivity to market this product
Cipla receives final approval for generic version of Migranal with a Competitive Generic Therapy… EP News Bureau May 21, 2020 Cipla is the “first approved applicant” for such CGT and, is therefore, eligible for 180 days of CGT exclusivity which will begin…
